See Credit Details Below
Why You Should Attend
Patent law is an ever-changing battlefield. The Federal Circuit and the U.S. Patent and Trademark Office (PTO) are continually reshaping it every year. This program will teach you about some of the key developments in 2023, as well as important trends and strategies that can be made to work for you. An experienced faculty will cover developments in district court litigation, appellate practice, the USPTO and ethics considerations.
This year’s topics include recent developments in biologic drugs and cell and gene therapies, the Supreme Court’s decision in Amgen v. Sanofi and its practical implications, what GSK v. Teva means for skinny labeling and best practices to consider, in-house perspectives on BPCIA litigation, how artificial intelligence is used in drug development and patent considerations, and ethics issues confronting patent lawyers and how to identify and mitigate associated risks in practice. Join us for these important and useful discussions on pressing issues in pharmaceutical and biotech patent law.
What You Will Learn
After completing this program, participants will be able to:
- Find out about patent issues confronting cell and gene therapy products
- Understand the practical implications, lessons learned, and open issues to be considered in light of the Supreme Court’s decision in Amgen v. Sanofi
- Learn about developments in the law of inducement
- Review issues in BPCIA litigation from the in-house perspective
- Understand how artificial intelligence is being used in drug development and patent considerations
- Explore ethics issues that impact patent practice
Who Should Attend
Attorneys who will find this program helpful include: in-house attorneys who want to understand the latest developments in biotech and pharmaceutical patent law including changes in the substantive law, future trends and strategic considerations; and, litigators who need to understand how to best make use of developing law relating to therapeutic antibodies, generic challenges to branded drug products, patent clearance best practices and strategies, and patent eligibility for life sciences patents.
Program Level: Overview
Prerequisites: An interest in the latest developments in pharmaceutical and biotech patent law.
Advanced Preparation: None